-
Courses
Courses
Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
-
University Life
University Life
Each year more than 4,000 choose University of Galway as their University of choice. Find out what life at University of Galway is all about here.
-
About University of Galway
About University of Galway
Since 1845, University of Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
-
Colleges & Schools
Colleges & Schools
University of Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
-
Research & Innovation
Research & Innovation
University of Galway’s vibrant research community take on some of the most pressing challenges of our times.
-
Business & Industry
Guiding Breakthrough Research at University of Galway
We explore and facilitate commercial opportunities for the research community at University of Galway, as well as facilitating industry partnership.
-
Alumni & Friends
Alumni & Friends
There are 128,000 University of Galway alumni worldwide. Stay connected to your alumni community! Join our social networks and update your details online.
-
Community Engagement
Community Engagement
At University of Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Staff Profiles
Dr Aideen Ryan
Biography
Research Projects
Project | Start Date | End Date | |
---|---|---|---|
RESTRAIN - Investigation of tumour stromal interactions in metastatic colon cancer for the identification of novel immuno-therapeutic targets | 01-DEC-16 | 30-NOV-21 | |
JANSSEN RESEARCH & DEVELOPMENT | 20-DEC-15 | 31-DEC-22 | |
NOS2&COX2 activation of TLR4 & EGFR signalling causes poor outcome in oestrogen receptor-negative breast cancer via pro-survival signals and immune polarisation | 01-MAY-14 | 01-MAY-17 | |
Cellular interactions in tumour microenvironment during inflammation associated | 01-OCT-13 | 01-OCT-17 | |
Molecular Regulation of the tumour Microenvironment in Colon Cancer Metastasis | 11-MAR-19 | 18-JUL-19 | |
Bristol-Myers Squibb Co.- Low dose cyclophosphamide, elotuzumab and nivolumab: a novel immunotherapeutic strategy for multiple myeloma | 13-FEB-18 | 13-FEB-23 | |
Molecular Regulation of the tumour microenvironment in colon cancer metastasis | 01-JAN-13 | 30-APR-16 | |
EI H2020 PROPOSAL PREP SUPPORT - INVESTIGATION OF COLON CANCER INDUCED STROMAL CELL IMMUNOLOGICAL AND METABOLIC PHENOTYPES AND SUBSEQUENT EFFECTS ON THE ANTI-TUMOUR IMMUNE RESPONSE | 31-JUL-17 | 30-APR-19 |
Contract Researchers
Researcher Name | Project | Role | Funding Body | |
---|---|---|---|---|
Dr Oliver Treacy | Investigation of tumour stromal interactions for the identification of novel immunotherapeutic targets | Senior Post Doctoral Researcher | ||
Dr Serika Naicker | Investigating novel methods for potentiation of monoclonal antibody therapies in cancer | Leading researcher on an industry funded project investigating methods to potentiate the effect of monoclonal antibody therapies for cancer | ||
Dr. Kevin Lynch | Bristol Myers Squibb | Post Doctoral Researcher |
Peer Reviewed Journals
Year | Publication | |
---|---|---|
(2021) | 'Stromal cells promote matrix deposition, remodelling and an immunosuppressive tumour microenvironment in a 3D model of colon cancer'
Leonard NA, Reidy E, Thompson K, McDermott E, Peerani E, Tomas-Bort E, Balkwill FR, Loessner D, Ryan AE (2021) 'Stromal cells promote matrix deposition, remodelling and an immunosuppressive tumour microenvironment in a 3D model of colon cancer'. Cancers, 13 (23) [Details] |
|
(2021) | 'Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment'
McGinity CL, Palmieri EM, Somasundaram V, Bhattacharyya DD, Ridnour LA, Cheng RYS, Ryan AE, Glynn SA, Thomas DD, Miranda KM, Anderson SK, Lockett SJ, McVicar DW, Wink DA. (2021) 'Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment'. International Journal Of Molecular Sciences, 22 (11) [DOI] [Details] |
|
(2021) | 'Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice'
Treacy O;Lynch K;Murphy N;Chen X;Donohoe E;Canning A;Lohan P;Shaw G;Fahy G;Ryan AE;Ritter T; (2021) 'Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice'. Stem Cell Research & Therapy, 12 (1) [DOI] [ARAN Link] [Details] |
|
(2021) | 'Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis'
Naicker SD;Feerick CL;Lynch K;Swan D;McEllistrim C;Henderson R;Leonard NA;Treacy O;Natoni A;Rigalou A;Cabral J;Chiu C;Sasser K;Ritter T;O'Dwyer M;Ryan AE; (2021) 'Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis'. Oncoimmunology, 10 (1) [DOI] [Details] |
|
(2020) | 'TGF-beta 1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo'
Lynch, K,Treacy, O,Chen, XZ,Murphy, N,Lohan, P,Islam, N,Donohoe, E,Griffin, MD,Watson, L,McLoughlin, S,O'Malley, G,Ryan, AE,Ritter, T (2020) 'TGF-beta 1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo'. Molecular Therapy, 28 :2023-2043 [DOI] [Details] |
|
(2020) | 'The pseudo-caspase FLIP(L) regulates cell fate following p53 activation'
Lees, A,McIntyre, AJ,Crawford, NT,Falcone, F,McCann, C,Holohan, C,Quinn, GP,Roberts, JZ,Sessler, T,Gallagher, PF,Gregg, GMA,McAllister, K,McLaughlin, KM,Allen, WL,Egan, LJ,Ryan, AE,Labonte-Wilson, MJ,Dunne, PD,Wappett, M,Coyle, VM,Johnston, PG,Kerr, EM,Longley, DB,McDade, SS (2020) 'The pseudo-caspase FLIP(L) regulates cell fate following p53 activation'. Proceedings Of The National Academy Of Sciences Of The United States Of America, 117 :17808-17819 [DOI] [Details] |
|
(2020) | 'Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot Study'
Watson L;Chen XZ;Ryan AE;Fleming Á;Carbin A;O'Flynn L;Loftus PG;Horan E;Connolly D;McDonnell P;McNamara LM;O'Brien T;Coleman CM; (2020) 'Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot Study'. Cells, 9 (6):1-20 [DOI] [Details] |
|
(2020) | 'Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma'
Swan D;Gurney M;Krawczyk J;Ryan AE;O'Dwyer M; (2020) 'Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma'. Hemasphere, 4 (2):1-10 [DOI] [Details] |
|
(2020) | 'TGF-ß1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo'
Lynch K;Treacy O;Chen X;Murphy N;Lohan P;Islam MN;Donohoe E;Griffin MD;Watson L;McLoughlin S;O'Malley G;Ryan AE;Ritter T; (2020) 'TGF-ß1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo'. Molecular Therapy : The Journal Of The American Society Of Gene Therapy, 28 (9):1-21 [DOI] [ARAN Link] [Details] |
|
(2019) | 'TNF-a/IL-1ß-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung'
Murphy N;Treacy O;Lynch K;Morcos M;Lohan P;Howard L;Fahy G;Griffin MD;Ryan AE;Ritter T; (2019) 'TNF-a/IL-1ß-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung'. Faseb Journal, 33 :9404-9421 [DOI] [ARAN Link] [Details] |
|
(2019) | 'CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study'
O'Dwyer, M;Henderson, R;Naicker, SD;Cahill, MR;Murphy, P;Mykytiv, V;Quinn, J;McEllistrim, C;Krawczyk, J;Walsh, J;Lenihan, E;Kenny, T;Hernando, A;Hirakata, G;Parker, I;Kinsella, E;Gannon, G;Natoni, A;Lynch, K;Ryan, AE (2019) 'CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study'. Blood Advances, 3 (12):1815-1825 [DOI] [Details] |
|
(2018) | 'Stromal Cell PD-L1 Inhibits CD8(+) T-cell Antitumor Immune Responses and Promotes Colon Cancer'
O'Malley, G,Treacy, O,Lynch, K,Naicker, SD,Leonard, NA,Lohan, P,Dunne, PD,Ritter, T,Egan, LJ,Ryan, AE (2018) 'Stromal Cell PD-L1 Inhibits CD8(+) T-cell Antitumor Immune Responses and Promotes Colon Cancer'. Cancer Immunology Research, 6 :1426-1441 [DOI] [ARAN Link] [Details] |
|
(2018) | 'Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat'
Lohan, P;Treacy, O;Morcos, M;Donohoe, E;O'donoghue, Y;Ryan, AE;Elliman, SJ;Ritter, T;Griffin, MD (2018) 'Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat'. Stem Cells (Dayton, Ohio), 36 :1210-1215 [DOI] [Details] |
|
(2018) | 'Extracellular vesicles as modulators of wound healing'
Cabral, J., Ryan, A.E., Griffin, M.D., Ritter, T. (2018) 'Extracellular vesicles as modulators of wound healing'. Advanced Drug Delivery Reviews, 129 :394-406 [DOI] [ARAN Link] [Details] |
|
(2018) | 'Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration'
Ridge, SM;Bhattacharyya, D;Dervan, E;Naicker, SD;Burke, AJ;Murphy, JM;O'leary, K;Greene, J;Ryan, AE;Sullivan, FJ;Glynn, SA (2018) 'Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration'. International Journal Of Cancer, 142 (10):2056-2067 [DOI] [Details] |
|
(2018) | 'Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation'
Lohan, P,Murphy, N,Treacy, O,Lynch, K,Morcos, M,Chen, BL,Ryan, AE,Griffin, MD,Ritter, T (2018) 'Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation'. Frontiers In Immunology, 9 :1-14 [DOI] [ARAN Link] [Details] |
|
(2017) | 'Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment'
Lynch, K,Treacy, O,Gerlach, JQ,Annuk, H,Lohan, P,Cabral, J,Joshi, L,Ryan, AE,Ritter, T (2017) 'Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment'. Frontiers In Immunology, 8 :1-16 [DOI] [ARAN Link] [Details] |
|
(2017) | 'Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways'
Garrido, P,Shalaby, A,Walsh, EM,Keane, N,Webber, M,Keane, MM,Sullivan, FJ,Kerin, MJ,Callagy, G,Ryan, AE,Glynn, SA (2017) 'Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways'. Oncotarget, 8 (46):80568-80588 [DOI] [Details] |
|
(2017) | 'Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer'
Basudhar D, Glynn SA, Greer M, Somasundaram V, No JH, Scheiblin DA, Garrido P, Heinz WF, Ryan AE, Weiss JM, Cheng RYS, Ridnour LA, Lockett SJ, McVicar DW, Ambs S, Wink DA. (2017) 'Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer'. Proceedings Of The National Academy Of Sciences Of The United States Of America, 114 (49):13030-13035 [DOI] [Details] |
|
(2017) | 'Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?'
Lohan, P;Treacy, O;Griffin, MD;Ritter, T;Ryan, AE (2017) 'Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?'. Frontiers In Immunology, 8 :1-8 [DOI] [ARAN Link] [Details] |
|
(2016) | 'Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes'
Ranera, B,Antczak, D,Miller, D,Doroshenkova, T,Ryan, A,McIlwraith, CW,Barry, F (2016) 'Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes'. Equine Veterinary Journal, 48 :253-260 [DOI] [Details] |
|
(2016) | 'Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity'
O'Leary, L,van der Sloot, AM,Reis, CR,Deegan, S,Ryan, AE,Dhami, SPS,Murillo, LS,Cool, RH,de Sampaio, PC,Thompson, K,Murphy, G,Quax, WJ,Serrano, L,Samali, A,Szegezdi, E (2016) 'Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity'. Oncogene, 35 :1261-1270 [DOI] [Details] |
|
(2016) | 'vIL-10-overexpressing human MSCs modulate naive and activated T lymphocytes following induction of collagenase-induced osteoarthritis'
Farrell, E,Fahy, N,Ryan, AE,Flatharta, CO,O'Flynn, L,Ritter, T,Murphy, JM (2016) 'vIL-10-overexpressing human MSCs modulate naive and activated T lymphocytes following induction of collagenase-induced osteoarthritis'. Stem Cell Research & Therapy, 7 (74):1-11 [DOI] [Details] |
|
(2016) | 'Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?'
O'Malley G;Heijltjes M;Houston AM;Rani S;Ritter T;Egan LJ;Ryan AE; (2016) 'Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?'. Oncotarget, 7 (37):60752-60774 [DOI] [Details] |
|
(2016) | 'Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response'
Lohan, P;Treacy, O;Lynch, K;Barry, F;Murphy, M;Griffin, MD;Ritter, T;Ryan, AE (2016) 'Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response'. Osteoarthritis And Cartilage, 24 :521-533 [DOI] [Details] |
|
(2015) | 'Immune Modulation to Improve Tissue Engineering Outcomes for Cartilage Repair in the Osteoarthritic Joint'
Fahy, N,Farrell, E,Ritter, T,Ryan, AE,Murphy, JM (2015) 'Immune Modulation to Improve Tissue Engineering Outcomes for Cartilage Repair in the Osteoarthritic Joint'. Tissue Engineering Part B-Reviews, 21 :55-66 [DOI] [Details] |
|
(2015) | 'Pullulan: a new cytoadhesive for cell-mediated cartilage repair'
Bulman, SE,Coleman, CM,Murphy, JM,Medcalf, N,Ryan, AE,Barry, F (2015) 'Pullulan: a new cytoadhesive for cell-mediated cartilage repair'. Stem Cell Research & Therapy, 6 (34):1-12 [DOI] [Details] |
|
(2015) | 'Targeting colon cancer cell NF-kappa B promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis'
Ryan, AE,Colleran, A,O'Gorman, A,O'Flynn, L,Pindjacova, J,Lohan, P,O'Malley, G,Nosov, M,Mureau, C,Egan, LJ (2015) 'Targeting colon cancer cell NF-kappa B promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis'. Oncogene, 34 :1563-1574 [DOI] [Details] |
|
(2015) | 'Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications'
Rani, S,Ryan, AE,Griffin, MD,Ritter, T (2015) 'Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications'. Molecular Therapy, 23 (5):812-823 [DOI] [Details] |
|
(2014) | 'Mesenchymal Stem Cell Therapy Promotes Corneal Allograft Survival in Rats by Local and Systemic Immunomodulation'
Treacy O, O'Flynn L, Ryan AE, Morcos M, Lohan P, Schu S, Wilk M, Fahy G, Griffin MD, Nosov M, Ritter T (2014) 'Mesenchymal Stem Cell Therapy Promotes Corneal Allograft Survival in Rats by Local and Systemic Immunomodulation'. American Journal Of Transplantation, 14 (9):2023-2036 [DOI] [Details] |
|
(2014) | 'Chondrogenic Differentiation Increases Antidonor Immune Response to Allogeneic Mesenchymal Stem Cell Transplantation'
Ryan, AE;Lohan, P;O'Flynn, L;Treacy, O;Chen, X;Coleman, C;Shaw, G;Murphy, M;Barry, F;Griffin, MD;Ritter, T (2014) 'Chondrogenic Differentiation Increases Antidonor Immune Response to Allogeneic Mesenchymal Stem Cell Transplantation'. Molecular Therapy : The Journal Of The American Society Of Gene Therapy, 22 :655-667 [DOI] [Details] |
|
(2014) | 'Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?'
Lohan P, Coleman CM, Murphy JM, Griffin MD, Ritter T, Ryan AE (2014) 'Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?'. Stem Cell Research & Therapy, 5 (4):1-11 [DOI] [Details] |
|
(2013) | 'Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury'
Curley GF, Ansari B, Hayes M, Devaney J, Masterson C, Ryan A, Barry F, O'Brien T, Toole DO, Laffey JG (2013) 'Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury'. Anesthesiology, 118 (4):924-932 [DOI] [Details] |
|
(2013) | 'Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?'
Griffin, MD,Ryan, AE,Alagesan, S,Lohan, P,Treacy, O,Ritter, T (2013) 'Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?'. Immunology And Cell Biology, 91 :40-51 [DOI] [Details] |
|
(2013) | 'Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer'
O'Callaghan, G,Ryan, A,Neary, P,O'Mahony, C,Shanahan, F,Houston, A (2013) 'Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer'. International Journal Of Cancer, 133 :825-834 [DOI] [Details] |
|
(2013) | 'Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu'
O'Flynn L, Treacy O, Ryan AE, Morcos M, Cregg M, Gerlach J, Joshi L, Nosov M, Ritter T (2013) 'Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu'. Molecular Therapy, 21 (11):2102-2112 [DOI] [ARAN Link] [Details] |
|
(2012) | 'Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation'
Treacy, O,Ryan, AE,Heinzl, T,O'Flynn, L,Cregg, M,Wilk, M,Odoardi, F,Lohan, P,O'Brien, T,Nosov, M,Ritter, T (2012) 'Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation'. Plos One, 7 (8):1-13 [DOI] [ARAN Link] [Details] |
|
(2012) | 'Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat'
Curley, GF;Hayes, M;Ansari, B;Shaw, G;Ryan, A;Barry, F;O'Brien, T;O'Toole, D;Laffey, JG (2012) 'Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat'. Thorax, 67 :496-501 [DOI] [Details] |
|
(2011) | 'Autophagosomal I kappa B alpha Degradation Plays a Role in the Long Term Control of Tumor Necrosis Factor-alpha-induced Nuclear Factor-kappa B (NF-kappa B) Activity'
Colleran, A,Ryan, A,O'Gorman, A,Mureau, C,Liptrot, C,Dockery, P,Fearnhead, H,Egan, LJ (2011) 'Autophagosomal I kappa B alpha Degradation Plays a Role in the Long Term Control of Tumor Necrosis Factor-alpha-induced Nuclear Factor-kappa B (NF-kappa B) Activity'. Journal Of Biological Chemistry, 286 :22886-22893 [DOI] [Details] |
|
(2010) | 'Regulation of NF-kappa B responses by epigenetic suppression of I kappa B alpha expression in HCT116 intestinal epithelial cells'
O'Gorman, A;Colleran, A;Ryan, A;Mann, J;Egan, LJ (2010) 'Regulation of NF-kappa B responses by epigenetic suppression of I kappa B alpha expression in HCT116 intestinal epithelial cells'. American Journal Of Physiology: Gastrointestinal And Liver Physiology, 299 :96-105 [DOI] [Details] |
|
(2008) | 'The Fas counterattack is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability'
Houston, AM,Michael-Robinson, JM,Walsh, MD,Cummings, MC,Ryan, AE,Lincoln, D,Pandeya, N,Jass, JR,Radford-Smith, GL,O'Connell, J (2008) 'The Fas counterattack is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability'. Human Pathology, 39 :243-250 [DOI] [Details] |
|
(2006) | 'Fas ligand promotes tumor immune evasion of colon cancer in vivo'
Ryan, AE,Shanahan, F,O'Connell, J,Houston, AM (2006) 'Fas ligand promotes tumor immune evasion of colon cancer in vivo'. Cell Cycle, 5 :246-249 [Details] |
|
(2006) | 'Fas ligand expression in human and mouse cancer cell lines ; a caveat on over-reliance on mRNA data'
Ryan AE, Lane S, Shanahan F, O'Connell J, Houston AM (2006) 'Fas ligand expression in human and mouse cancer cell lines ; a caveat on over-reliance on mRNA data'. Carcinogenesis, 5 (1):1-5 [Details] |
|
(2006) | 'Induction of apoptosis in renal cell carcinoma by reactive oxygen species: Involvement of extracellular signal-regulated kinase 1/2, p38 delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor'
Ambrose, M,Ryan, A,O'Sullivan, GC,Dunne, C,Barry, OP (2006) 'Induction of apoptosis in renal cell carcinoma by reactive oxygen species: Involvement of extracellular signal-regulated kinase 1/2, p38 delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor'. Molecular Pharmacology, 69 :1879-1890 [DOI] [Details] |
|
(2005) | 'Addressing the Fas counterattack controversy: Blocking Fas ligand expression suppresses tumor immune evasion of colon cancer in vivo'
Ryan, AE,Shanahan, F,O'Connell, J,Houston, AM (2005) 'Addressing the Fas counterattack controversy: Blocking Fas ligand expression suppresses tumor immune evasion of colon cancer in vivo'. Cancer Research, 65 :9817-9823 [DOI] [Details] |
|
(2002) | 'Rapid development of a quantitative –competitive (qc) RT-PCR assay using a composite primer approach'
O'Connell J, Houston AM, Kelly R, O'Brien D, Ryan AE, Bennett, MW, Nally K (2002) 'Rapid development of a quantitative –competitive (qc) RT-PCR assay using a composite primer approach'. Methods in Molecular Biology, 193 :93-102 [Details] |
Book Chapters
Year | Publication | |
---|---|---|
(2016) | 'Mesenchymal Stem/Stromal cell Therapy: mechanism of action and host response'
Aideen E Ryan, Mary M Murphy, Frank P Barry (2016) 'Mesenchymal Stem/Stromal cell Therapy: mechanism of action and host response' In: Biology and Therapeutic Applications of Mesenchymal Stromal Cells. :426-440 USA: Wiley Publishers. [DOI] [Details] |
|
(2015) | 'Mechanisms of Nitric Oxide Dependent Regulation of Tumour Invasion and Metastasis'
Ryan AE, Burke AJ, Sullivan FJ, Glynn SA (2015) 'Mechanisms of Nitric Oxide Dependent Regulation of Tumour Invasion and Metastasis' In: ‘NO and Cancer’ – Prognosis, Prevention and Therapy. :49-64 USA: Springer. [DOI] [Details] |
Conference Publications
Year | Publication | |
---|---|---|
(2020) | Elucidating the Circulating and Tumour-Specific Immune Populations in a Cohort of Colon Cancer Patients
Samy, A,Treacy, O,Leonard, N,Lynch, K,Hynes, S,Sheehan, M,Egan, L,Hogan, A,Ryan, A (2020) BRITISH JOURNAL OF SURGERY Elucidating the Circulating and Tumour-Specific Immune Populations in a Cohort of Colon Cancer Patients , pp.158-158 [Details] |
|
(2019) | IMMUNOMODULATORY ABILITIES OF LICENSED MESENCHYMAL STEM CELLS: A POTENTIAL THERAPEUTIC STRATEGY IN OSTEOARTHRITIS
Hennessy, C,Mancuso, P,Ivanovska, A,Burke, A,Mukeria, E,Ritter, T,Barry, F,Murphy, M,Ryan, A (2019) OSTEOARTHRITIS AND CARTILAGE IMMUNOMODULATORY ABILITIES OF LICENSED MESENCHYMAL STEM CELLS: A POTENTIAL THERAPEUTIC STRATEGY IN OSTEOARTHRITIS , pp.375-375 [Details] |
|
(2019) | Mesenchymal Stromal Cell Sialylation Modulates Antitumor Immune Responses In Multiple Myeloma
Lynch, K,De Veirman, K,Egan, H,Leonard, N,O'Malley, G,Ritter, T,Ryan, A,O'Dwyer, M (2019) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Mesenchymal Stromal Cell Sialylation Modulates Antitumor Immune Responses In Multiple Myeloma , pp.93-94 [Details] |
|
(2019) | The role of sialylation in stromal cell mediated immunosuppression in the colorectal tumour microenvironment
Egan, H,Lynch, K,Leonard, N,Egan, MOL,Ritter, T,Treacy, O,Ryan, A (2019) JOURNAL FOR IMMUNOTHERAPY OF CANCER The role of sialylation in stromal cell mediated immunosuppression in the colorectal tumour microenvironment [Details] |
|
(2018) | Annual Meeting of the American Association for Cancer Research
Basudhar, D,Glynn, S,Greer, M,Somasundaram, V,No, JH,Scheiblin, DA,Garrido, P,Heinz, WF,Ryan, AE,Weiss, JM,Cheng, RY,Ridnour, LA,Lockett, SJ,McVicar, DW,Ambs, S,Wink, DA (2018) Role of NOS2-COX2 crosstalk in tumor microenvironment of estrogen receptor-negative breast cancer and its therapeutic implications . In: Cancer Research eds. Annual Meeting of the American Association for Cancer Research USA, [DOI] [Details] |
|
(2016) | Licensing of recipient-derived mesenchymal stem cells enhances their immunosuppressive properties and prolongs corneal allograft survival in rats
Treacy, O,Murphy, N,Ryan, AE,Lohan, P,Lynch, K,Morcos, M,Fahy, G,Griffin, M,Ritter, T (2016) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Licensing of recipient-derived mesenchymal stem cells enhances their immunosuppressive properties and prolongs corneal allograft survival in rats [Details] |
|
(2016) | Extracellular vesicles derived from human mesenchymal stem cells promote corneal wound repair by increasing epithelial cell proliferation and reducing neovascularisation in a rat corneal alkali burn model
Ritter, T,Lal, C,Treacy, O,O'Malley, GA,Naicker, S,Elbadawy, H,Ryan, AE,Fahy, G,Leahy, MJ,Griffin, M,Rani, S (2016) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Extracellular vesicles derived from human mesenchymal stem cells promote corneal wound repair by increasing epithelial cell proliferation and reducing neovascularisation in a rat corneal alkali burn model [Details] |
|
(2015) | OARSI
Lohan P, Treacy O;Lynch K;Barry F;Murphy M;Griffin MD;Ritter T;Ryan AE (2015) Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response OARSI [DOI] [Details] |
|
(2015) | Mesenchymal stem cell-derived extracellular vesicles promote corneal wound repair
Ritter, T,O'Malley, GA,Lohan, P,Ryan, A,Griffin, M,Rani, S (2015) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Mesenchymal stem cell-derived extracellular vesicles promote corneal wound repair [Details] |
|
(2015) | ALLOGENEIC CHONDROPROGENITORS DISPLAY IMMUNOSUPPRESSIVE PROPERTIES AND ARE NON-IMMUNOGENIC IN VITRO
Lohan, P,Treacy, O,Lynch, K,Griffin, M,Ritter, T,Ryan, AE (2015) OSTEOARTHRITIS AND CARTILAGE ALLOGENEIC CHONDROPROGENITORS DISPLAY IMMUNOSUPPRESSIVE PROPERTIES AND ARE NON-IMMUNOGENIC IN VITRO , pp.267-267 [Details] |
|
(2014) | Annual Scientific Meeting of the British-Association-of-Urological-Surgeons (BAUS)
Ridge, M,Ridge, SM,Ryan, AE,Finn, S,O'Leary, J,Giles, FJ,Sullivan, FJ,Glynn, SA (2014) Prostate Cancer Mediated Differentiation of Bone-Marrow Derived Mesenchymal Stem Cells Facilitates Prostate Cancer Cell Invasive and Migratory Capacity . In: BJU INTERNATIONAL, 113, S5, 28-28 eds. Annual Scientific Meeting of the British-Association-of-Urological-Surgeons (BAUS) Liverpool, England, [Details] |
|
(2012) | Attenuation of inflammation by immune modulation for cartilage repair in osteoarthritis
Fahy, N,Farrell, E,Ryan, A,Harte, M,Ritter, T,Murphy, M (2012) JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE Attenuation of inflammation by immune modulation for cartilage repair in osteoarthritis , pp.63-63 [Details] |
|
(2005) | Endoscopy
Ryan AE, Shanahan F, O’Connell J, Houston AM (2005) Endoscopy , pp.A-18 [Details] |
|
(2012) | RAMI Biomedical Sciences Conference Galway
Fahy, N,Farrell, E,Ryan, A,Harte, M,Ritter, T,Murphy, M (2012) MECHANISM OF ACTION OF ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN-10 OVEREXPRESSING MESENCHYMAL STEM CELLS RAMI Biomedical Sciences Conference Galway [Details] |
|
(2011) | Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation
Treacy, O,Heinzl, T,Cregg, M,Wilk, M,Odoardi, F,O'Brien, T,Ryan, A,Nosov, M,Ritter, T (2011) Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation , pp.72-72 [Details] |
Abstract
Year | Publication | |
---|---|---|
(2014) | BJU International.
SM Ridge, AE Ryan, S Finn, J O'Leary, FJ Giles, FJ Sullivan, SA Glynn (2014) BJU International. Abstract [Details] |
|
(2012) | Gastroenterology.
GP O'Callaghan, AE Ryan, P Neary, C O'Mahony, F Shanahan, A Houston (2012) Gastroenterology. Abstract [Details] |
|
(2012) | Acta Ophthalmologica.
L O'Flynn, O Treacy, AE Ryan, M Morcos, M Nosov, T Ritter (2012) Acta Ophthalmologica. Abstract [Details] |
|
(2012) | Section of Biomedical Sciences.
N Fahy, E Farrell, AE Ryan, M Harte, T Ritter, M Murphy (2012) Section of Biomedical Sciences. Abstract [Details] |
|
(2012) | Journal of Tissue Engineering and Regenerative Medicine.
N Fahy, E Farrell, AE Ryan, M Harte, T Ritter, M Murphy (2012) Journal of Tissue Engineering and Regenerative Medicine. Abstract [Details] |
|
(2011) | Acta Ophthalmologica.
T Ritter, O Treacy, M Wilk, M Morcos, L O'Flynn, AE Ryan, M Nosov (2011) Acta Ophthalmologica. Abstract [Details] |
|
(2010) | Gastroenterology.
Ryan AE, Colleran A, O'Gorman A, Mureau C, Egan LJ (2010) Gastroenterology. Abstract [Details] |
|
(2010) | Gastroenterology Presentation.
Colleran A, Ryan AE, O’Gorman A, Liptrot CH, Dockery P, Egan LJ (2010) Gastroenterology Presentation. Abstract [Details] |
|
(2010) | Gastroenterology.
Raja Affendi Raja Ali, Zulquernain SA, Ryan AE, Colleran A, Hartnett L, O’Gorman A, Lee JM, Egan LJ (2010) Gastroenterology. Abstract [Details] |
|
(2009) | Gastroenterology.
Ryan AE, Colleran A, O’Gorman A, Foran E, Egan LJ (2009) Gastroenterology. Abstract [Details] |
|
(2005) | Gastroenterology.
Ryan AE, Shanahan F, O’Connell J, Houston AM (2005) Gastroenterology. Abstract [Details] |
Book Review
Year | Publication | |
---|---|---|
(2019) | Subconjunctival injection of low-dose mesenchymal stem cells promotes corneal allograft survival in a mouse cornea transplantation model.
Ritter, T,Donohoe, E,Treacy, O,Lynch, K,Chen, XZ,Fahy, G,Ryan, AE,Murphy, N (2019) Subconjunctival injection of low-dose mesenchymal stem cells promotes corneal allograft survival in a mouse cornea transplantation model. Book Review [Details] |
|
(2016) | Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries.
Ritter, T,Lal, C,Treacy, O,O'Malley, G,Naughton, M,Naicker, S,Lohan, P,Subhash, HM,Ryan, A,Fahy, G,Leahy, M,Griffin, MD,Rani, S (2016) Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries. Book Review [Details] |
|
(2016) | Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries.
Ritter, T,Lal, C,Treacy, O,O'Malley, G,Naughton, M,Naicker, S,Lohan, P,Subhash, HM,Ryan, A,Fahy, G,Leahy, M,Griffin, MD,Rani, S (2016) Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries. Book Review [Details] |
|
(2016) | Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries.
Ritter, T,Lal, C,Treacy, O,O'Malley, G,Naughton, M,Naicker, S,Lohan, P,Subhash, HM,Ryan, A,Fahy, G,Leahy, M,Griffin, MD,Rani, S (2016) Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries. Book Review [Details] |
Invited Seminars
Year | Publication | |
---|---|---|
(2012) | The Immunology Seminar Series, NUI Maynooth.
Ryan, AE (2012) The Immunology Seminar Series, NUI Maynooth. Invited Seminars [Details] |
|
(2012) | Biochemistry Seminar Series’, University College Cork.
Ryan, AE (2012) Biochemistry Seminar Series’, University College Cork. Invited Seminars [Details] |
|
(2011) | PRTLI Workshop on ‘Inflammation’, Trinity College Dublin.
Ryan, AE (2011) PRTLI Workshop on ‘Inflammation’, Trinity College Dublin. Invited Seminars [Details] |
|
(2009) | Irish Epithelial Physiology Group (IEPG), Kilkenny.
Ryan, AE (2009) Irish Epithelial Physiology Group (IEPG), Kilkenny. Invited Seminars [Details] |
Presented Papers
Year | Publication | |
---|---|---|
(2013) | Irish Association for Cancer research.
Ryan, AE (2013) Irish Association for Cancer research. Presented Papers [Details] |
|
(2012) | Keystone Symposium on ‘The role of Inflammation during Carcinogenesis’.
Ryan, AE (2012) Keystone Symposium on ‘The role of Inflammation during Carcinogenesis’. Presented Papers [Details] |
|
(2005) | Irish Society Gastroenterology.
Ryan, AE (2005) Irish Society Gastroenterology. Presented Papers [Details] |
Reviews
Year | Publication | |
---|---|---|
(2020) | Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma.
Swan, D;Gurney, M;Krawczyk, J;Ryan, AE;O'Dwyer, M (2020) Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS Reviews [DOI] [Details] |
|
(2013) | Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?.
Griffin, MD;Ryan, AE;Alagesan, S;Lohan, P;Treacy, O;Ritter, T (2013) Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?. HOBOKEN: WILEY Reviews [DOI] [Details] |
|
(2014) | Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?.
Lohan, P;Coleman, CM;Murphy, M;Griffin, MD;Ritter, T;Ryan, AE (2014) Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?. LONDON: BIOMED CENTRAL LTD Reviews [DOI] [Details] |
|
(2015) | Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.
Rani, S;Ryan, AE;Griffin, MD;Ritter, T (2015) Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. CAMBRIDGE: CELL PRESS Reviews [DOI] [Details] |
|
(2016) | Mesenchymal stromal cells (MSCs) and colorectal cancer - a troublesome twosome for the anti-tumour immune response?.
O'Malley, G;Heijltjes, M;Houston, AM;Rani, S;Ritter, T;Egan, LJ;Ryan, AE (2016) Mesenchymal stromal cells (MSCs) and colorectal cancer - a troublesome twosome for the anti-tumour immune response?. ORCHARD PARK: IMPACT JOURNALS LLC Reviews [DOI] [Details] |
|
(2018) | Extracellular vesicles as modulators of wound healing.
Cabral, J;Ryan, AE;Griffin, MD;Ritter, T (2018) Extracellular vesicles as modulators of wound healing. AMSTERDAM: ELSEVIER SCIENCE BV Reviews [DOI] [Details] |
Honours and Awards
Year | Title | Awarding Body | |
---|---|---|---|
2018 | Sparkathon 'Future Leader' Award | Society for Immunotherapy of Cancer | |
2018 | NCI Cancer Prevention Fellowship | Health research Board, National cancer Institute, USA | |
2018 | Presidents Award for Research Excellence | Presidents Office, NUI Galway | |
2017 | Recognition as one of the top 3 Cancer Researchers in Ireland for 'Researcher of the year' | Irish Cancer Society | |
2016 | Shortlisted for Researcher of the Year Award | Irish Cancer Society | |
2016 | Best Clinical Research Presentation | Haematology Association of Ireland | |
2016 | Starting Investigator Award | Science Foundation Ireland | |
2016 | IRC nomination attendee at the Preseidents address to Women in Science | Irish Research Council | |
2015 | Best Reseach Poster Presentation | The Irish Association of Cancer Research | |
2015 | European Cancer Research Young Investigator Award | European Association for Cancer Research | |
2015 | Highly Rcommended shortlst 'Presidents awards for research excellence' | National University of Ireland, Galway | |
2015 | Best Research Poster | Irish Association of Cancer Research | |
2014 | Lindau Nobel Laureate Meeting Award | Lindau Nobel Laureate Council & The Irish Research Council | |
2013 | Irish Cancer Society Research Fellowship | Irish Cancer Society | |
2012 | Best Research Presentation | The Irish Society of Immunology | |
2007 | Best Research Presentation | Irish Association of Cancer Research | |
2005 | Research Travel Scholarship | Irish Cancer Society |
Professional Associations
Association | Function | From / To | |
---|---|---|---|
European Association of Cancer Research | Member | 31-MAY-20 / 31-MAY-21 | |
Irish Association of Cancer Research | Member | 23-MAY-20 / | |
American Society of Haematology | Active Member | 01-NOV-19 / | |
American Association of Cancer Research | Active Member | 01-NOV-18 / | |
Matrix Biology Ireland | Committee Member | 01-OCT-19 / | |
Haematology Association of Ireland | Active Member | 01-OCT-19 / | |
Irish Society of Immunology | Member | 30-MAY-12 / 12-MAY-16 | |
Irish Flow Cytometry Society | Member | 01-OCT-12 / | |
Society for Immunotherapy for Cancer | Active Member | 01-FEB-20 / 01-JAN-21 |
Committees
Committee | Function | From / To | |
---|---|---|---|
School of Medicine Research Committee | Committee Member | 01-DEC-17 / | |
School of Medicine Athena Swan Committee Member | Committee Member | 01-FEB-17 / | |
Research Advisory Board Irish Cancer Society | Advisor to the research portfolio of the charity | 15-NOV-16 / | |
Undergraduate Research Commitee | Member of Commitee | 01-SEP-14 / | |
Graduate Research Commitee | GRC Commitee member | 01-JUL-14 / 30-JUN-17 |
Employment
Employer | Position | From / To | |
---|---|---|---|
Prof Laurence Egan, NUI Galway | Post Doctoral Fellow | 01-AUG-06 / 31-MAR-10 | |
NUI Galway | Research Fellow | 01-JAN-13 / 01-MAY-16 | |
Prof Thomas Ritter, NUI Galway | Senior Post Doctoral Fellow | 04-NOV-10 / 31-DEC-12 | |
NUI Galway | SFI Funded Starting Investigator | 01-DEC-16 / |
Education
Year | Institution | Qualification | Subject | |
---|---|---|---|---|
2010 | Project Management Institute | Certificate | Project Management | |
2018 | NUI Galway | Postgraduate Certificate in Teaching & Learning in Higher Education | Teaching and Learning | |
2001 | National University of Ireland, Galway | BSc (Hons) | Biochenistry, Microbiology | |
2006 | University College Cork | PhD | Medicine | |
1997 | Scoil Mhuire Ballinasloe | Leaving Certificate | 7 |
Languages
Language | |
---|---|
Irish | |
English |
Community Engagement
Title | Type | From / To | |
---|---|---|---|
Outreach | Cell Explorers School Visits | 01-NOV-17 / | |
Outreach | Research Advocate at the Irish Cancer Society Daffodil Day launch | 03-MAR-16 / | |
Outreach | Adjudicator for 'Reellife' Science Competition | 04-FEB-14 / 30-NOV-15 | |
Outreach | Pint of Science Talk | 03-FEB-16 / | |
Outreach | Irish Cancer Society Fundraising Research Showcase | 30-JUN-13 / 27-MAY-13 | |
Board Membership | Research Advisory Board of the Irish Cancer Society | 16-NOV-16 / | |
Research (e.g. Community based research) | Irish Cancer Society Research Day launch | 09-JUN-14 / 09-JUN-14 |
Reviews
Journal | Role | |
---|---|---|
Stem Cell Research And Therapy | Reviewer | |
Journal Of Tissue Engineering And Regenerative Medicine | Editoral Board | |
Immunology And Cell Biology | Reviewer | |
Osteoarthritis And Cartilage | Reviewer | |
Transplantation | Reviewer | |
Cells Tissues Organs | Reviewer | |
Stem Cell Reviews And Reports | Reviewer | |
Transplant immunology | Reviewer | |
Molecular Therapy | Reviewer | |
Stem Cells And Development | Reviewer | |
Plos One | Reviewer |
Teaching Interests
Recent Postgraduate Students
Graduation | Name | Degree | Primary Supervisor | |
---|---|---|---|---|
2018 | Grace O'Malley | PhD | Y | |
2016 | Paul Lohan | PhD | Y |
Modules Taught
Term/Year | Module Title | Module Code | Subject / Desc | |
---|---|---|---|---|
2012-2018 | Clinical Oncology, Haematology | B1461 | Gastrointestinal Cancers | |
2016/2017 | Molecular Pharmacology | 1617-PM434 | ||
2016/2017 | Clinical Oncology - Haematology | 1617-B1461 | ||
2016/2017 | Advnaced and Applied Immunology | 1617-MD536 | ||
2020/21 | Advanced and Applied Immunology | MD536 | Cancer Immunology ans Immunotherapies | |
2016/2017 | Pharmacology Research Project | 1617-PM431 | ||
2019/20 | Course in Basic and Applied Immunology | REM508 | Cancer and stromal cell immunology | |
2019/2020 | Clinical Oncology, Haematology | B1461 | Gastrointestinal Cancers | |
2020/21 | Course in Basic and Advanced Immunology | REM508 | Stem Cell Immunology | |
2015-2016 | Basic and Advanced Immunology | 1516-REM508 | Stem Cell transplantation | |
2016/2017 | Stem Cells and Gene Therapy | 1617-PM507 | ||
2020/21 | Clinical Oncology, Haematology | B1461 | Gastrointestinal Cancers | |
2016/2017 | Immunopharmacology | 1617-PM435 | ||
2016/2017 | Basic and Advanced Immunology | 1617-REM508 | ||
2016/2017 | Experimental Neuropharmacology | 1617-PM5103 | ||
2016/2017 | Experimental Toxicology | 1617-PM5109 |
Internal Collaborators
Name | Description of Collaboration | |
---|---|---|
Prof Laurence Egan | ||
Dr Sharon Glynn | ||
Dr Mary Murphy | ||
Dr Roisin Dwyer | ||
Prof Michael O'Dwyer |
External Collaborators
Name | Organisation / Institute | Country | Description of Collaboration | |
---|---|---|---|---|
Dr Christopher Chiu | Janssen Pharmaceuticals | U.S.A. | ||
Prof Karin Vanderkerken | VUB | BELGIUM | ||
Dr Philip Dunne | Queens University Belfast | UNITED KINGDOM | ||
Dr David Wink | National Cancer Insititute, Frederick, MD, USA | U.S.A. |